Table 1.
Demographic features, laboratory parameters, treatments, and outcomes of patients with iTTP (n = 97)
| Parameters | Values* |
|---|---|
| Age, y (n = 97) | 45 (34-52.5) |
| Sex (n = 83) | |
| Female | 47 (56.6) |
| Male | 36 (43.4) |
| Race (n = 83) | |
| African American | 68 (81.9) |
| White | 15 (18.1) |
| Disease status (n = 97) | |
| Initial | 60 (61.9) |
| Relapse | 37 (38.1) |
| Blood group (n = 83) | |
| O | 45 (54.2) |
| Non-O | 38 (45.8) |
| BMI | 33.6 (29.0-41.0) |
| Comorbidities | |
| Hypertension (n = 97) | 48 (49.5) |
| Diabetes mellitus (n = 97) | 22 (22.7) |
| SLE (n = 44) | 8 (18.2) |
| HIV (n = 67) | 6 (9.0) |
| Symptoms (n = 97) | |
| CNS symptoms | 52 (53.6) |
| Fever | 16 (16.5) |
| Chest pain | 13 (13.4) |
| Abdominal pain | 25 (25.8) |
CNS, central nervous system; O, blood type O; SLE, systemic lupus erythematosus.
*
Age and BMI are expressed as the median (IQR). All other parameters are expressed as n (%) of patients.